TB Genome Annotation Portal

Rv3031 (-)

Amino Acid Sequence

LNTSASPVPGLFTLVLHTHLPWLAHHGRWPVGEEWLYQSWAAAYLPLLQVLAALADENRHRLITLGMTPVVNAQLDDPYCLNGVHHWLANWQLRAEEAAS
VRYARQSKSADYPSCTPEALRAFGIRECADAARALDNFATRWRHGGSPLLRGLIDAGTVELLGGPLAHPFQPLLAPRLREFALREGLADAQLRLAHRPKG
IWAPECAYAPGMEVDYATAGVSHFMVDGPSLHGDTALGRPVGKTDVVAFGRDLQVSYRVWSPKSGYPGHAAYRDFHTYDHLTGLKPARVTGRNVPSEQKA
PYDPERADRAVDVHVADFVDVVRNRLLSESERIGRPAHVIAAFDTELFGHWWYEGPTWLQRVLRALPAAGVRVGTLSDAIADGFVGDPVELPPSSWGSGK
DWQVWSGAKVADLVQLNSEVVDTALTTIDKALAQTASLDGPLPRDHVADQILRETLLTVSSDWPFMVSKDSAADYARYRAHLHAHATREIAGALAAGRRD
TARRLAEGWNRADGLFGALDARRLPK
(Nucleotide sequence available on KEGG)

Additional Information

possible paralog of GlgB
probable 1,4-alpha-glucan branching enzyme

ESSENTIALITY

MtbTnDB - interactive tool for exploring a database of published TnSeq datasets for Mtb

TnSeqCorr - genes with correlated TnSeq profiles across ~100 conditions

Rv3031/-, gene len: 1580 bp, num TA sites: 20
conditiondatasetcallmediummethodnotes
in-vitroDeJesus 2017 mBioessential7H9HMMfully saturated, 14 TnSeq libraries combined
in-vitroSassetti 2003 Mol Microessential 7H9TRASHessential if hybridization ratio<0.2
in-vivo (mice)Sassetti 2003 PNASnon-essential BL6 miceTRASHessential if hybridization ratio<0.4, min over 4 timepoints (1-8 weeks)
in-vitro (glycerol)Griffin 2011 PPathessentialM9 minimal+glycerolGumbel2 replicates; Padj<0.05
in-vitro (cholesterol)Griffin 2011 PPathessentialM9 minimal+cholesterolGumbel3 replicates; Padj<0.05
differentially essential in cholesterol Griffin 2011 PPathNO (LFC=0.0)cholesterol vs glycerolresampling-SRYES if Padj<0.05, else not significant; LFC<0 means less insertions/more essential in cholesterol
in-vitroSmith 2022 eLifeessential7H9HMM6 replicates (raw data in Subramaniam 2017, PMID 31752678)
in-vivo (mice)Smith 2022 eLifeessentialBL6 miceHMM6 replicates (raw data in Subramaniam 2017, PMID 31752678)
differentially essential in miceSmith 2022 eLifeNO (LFC=0.0)in-vivo vs in-vitroZINBYES if Padj<0.05, else not significant; LFC<0 means less insertions/more essential in mice
in-vitro (minimal)Minato 2019 mSysnon-essentialminimal mediumHMM
in-vitro (YM rich medium)Minato 2019 mSysessentialYM rich mediumHMM7H9 supplemented with ~20 metabolites (amino acids, cofactors)
differentially essential in YM rich mediumMinato 2019 mSysYES (LFC=-3.8)YM rich vs minimal mediumresampling

Analysis of Positive Selection in Clinical Isolates *new*

global set of 10,626 Mtb clinical isolates
under significant positive selection?NO
omega peak height (95%CI lower bound)1.66 (0.51)
codons under selection
omega plotsomega plot across ORF
genetic variants*link
* example format for variants: "D27 (GAC): D27H (CAC,11)" means "Asp27 (native codon GAC) mutated to His (codon CAC) in 11 isolates"



TnSeq Data No data currently available.
  • No TnSeq data currently available for this Target.
RNASeq Data No data currently available.
  • No RNA-Seq data currently available for this Target.
Metabolomic Profiles No data currently available.
  • No Metabolomic data currently available for this Target.
Proteomic Data No data currently available.
  • No Proteomic data currently available for this Target.

Regulatory Relationships from Systems Biology
  • BioCyc

    Gene interactions based on ChIPSeq and Transcription Factor Over-Expression (TFOE) (Systems Biology)

    NOTE: see table of TFOE interactions below

    Interactions based on ChIPSeq data

  • Interactions based on ChIPSeq data (Minch et al. 2014)

    • Binds To:

      • No bindings to other targets were found.
    • Bound By:

    Interactions based on TFOE data (Rustad et al. 2014)

    TFOE = Transcription Factor Over-Expression study
    significance criteria used in paper: greater than 2-fold change (|LFC|>=1.0) and Padj<0.01

    genedysregulated by OE ofLFC
    Rv3031/-Rv0818/glnR-1.05
    Rv3031/-Rv3223c/sigH-1.19
    Rv3031/-Rv0023/--1.37
    Rv3031/-Rv2034/--1.38
    Rv3031/-Rv0022c/whiB5-1.39
    Rv3031/-Rv2506/--1.5
    Rv3031/-Rv3286c/sigF-1.56
    Rv3031/-Rv0576/--1.6


    TBCAP

    Tubculosis Community Annotation Project (
    Slayden et al., 2013)

    Rv3031 (-)

    PropertyValueCreatorEvidencePMIDComment
    NamePutative branching enzyme involved in methylglucose lipolysaccharide synthesismjacksonISSOther (lipo)polysaccharides [Methylglucose lipolysaccharides, glycogen and capsular alpha-1,4 glucan]
    CitationGenetic basis for the biosynthesis of methylglucose lipopolysaccharides in Mycobacterium tuberculosis. G. Stadthagen, T. Sambou et al. J. Biol. Chem. 2007mjackson17640872Putative branching enzyme involved in methylglucose lipolysaccharide synthesis
    OtherTBPWY:(MGLP and alpha-1,4 glucans)mjacksonPutative branching enzyme involved in methylglucose lipolysaccharide synthesis
    G. Stadthagen, T. Sambou et al. Genetic basis for the biosynthesis of methylglucose lipopolysaccharides in Mycobacterium tuberculosis. J. Biol. Chem. 2007
    CitationPolymethylated polysaccharides from Mycobacterium species revisited. authors,M. Jackson,PJ. Brennan J. Biol. Chem. 2009mjackson18786916Putative branching enzyme involved in methylglucose lipolysaccharide synthesis
    OtherTBPWY:(MGLP and alpha-1,4 glucans)mjacksonPutative branching enzyme involved in methylglucose lipolysaccharide synthesis
    authors,M. Jackson,PJ. Brennan Polymethylated polysaccharides from Mycobacterium species revisited. J. Biol. Chem. 2009

    Comments